Company intelligence / Profile preview

SkyMedAI

Boston, Massachusetts, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

SkyMedAI is an active company at the center of the healthcare artificial intelligence ecosystem. It leverages deep industry expertise to help clients in pharma, healthcare, and modern medicine implement pioneering AI solutions. The company focuses on bridging gaps in digital health innovation by providing strategic guidance and execution support for organizations seeking to integrate advanced AI into their operations. There are no clinical results or therapeutic programs as it does not develop drugs.

Industry: Consulting

Partnerships

Co-organizer/partner of the Digital Health & AI Innovation Summit ("DHAI Summit")

Beyond the preview

Go deeper on SkyMedAI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkyMedAI.

Explore the full profile